Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06235814 · ClinicalTrials.gov registry record · NA
Molecular Analysis for Precision Surgery in Thyroid Cancer Trial
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06235814 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 2 participants.
The verdict
NCT06235814, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Ideal surgical extent for differentiated thyroid cancer remains unclear. Routine use of molecular analysis in biopsy-proven thyroid cancer could provide important prognostic information to help guide extent of surgery - thyroid lobectomy versus total thyroidectomy. This is a pilot feasibility study for the use of routine molecular analysis in Bethesda V and VI thyroid cancers, with randomization of the intermediate-molecular risk subgroup to thyroid lobectomy and total thyroidectomy. The investigators hypothesize that patients will 1) agree to preoperative molecular analysis, and 2) 50% of intermediate-risk patients will agree to and follow through with randomization. This will be a pilot study for a future randomized controlled trial (RTC) to compare between the two surgical approaches in intermediate-molecular risk thyroid cancer.
Interventions
- PROCEDURE Molecular Analysis for Thyroid Resection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2024-02-19 |
| Est. Completion | 2026-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06235814
The ClinicalTrials.gov registry entry for NCT06235814 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Molecular Analysis for Thyroid Resection is the first listed.
NCT06235814 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06235814 about?
NCT06235814 is a clinical study titled "Molecular Analysis for Precision Surgery in Thyroid Cancer Trial". Ideal surgical extent for differentiated thyroid cancer remains unclear. Routine use of molecular analysis in biopsy-proven thyroid cancer could provide important prognostic information to help guide extent of surgery - thyroid lobectomy versus total thyroidectomy. This is a pilot feasibility study ...
What is the current status of trial NCT06235814?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2024-02-19. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT06235814?
The interventions under investigation include: Molecular Analysis for Thyroid Resection (PROCEDURE).
Who is sponsoring clinical trial NCT06235814?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.